Floatz logo

Folic Acid

Diabetic Kidney Disease

Fuling Central Hospital of Chongqing CitySmall moleculePhase 2/3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Diabetic Kidney Disease cohort.

Asset / SponsorPhaseRating
Valsartan
Columbia University
Phase 4BB
Spironolactone
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Phase 4BB
Nifedipine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3BB
Lisinopril
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3BB
Simvastatin
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3BB

View all 17 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaActive
BBB
Indicative · Phase 4
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative · Phase 4
72 / 100
View asset →
polycystic ovary syndromeActive
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →